PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E86.
   PubMed Web of Science ®Google Scholar
• Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013;47(Suppl):S2–S6.
   PubMed Web of Science ®Google Scholar
• M C, Terashita K, Sakamoto N, et al. New molecularly targeted therapies against advanced hepatocellular carcinoma: from molecular pathogenesis to clinical trials and future directions. Hepatol Res. 2015;45:E1–E11.
   PubMed Web of Science ®Google Scholar
• Lapidot TSC, Vormoor J, Murdoch B, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645–648.
   PubMed Web of Science ®Google Scholar
• Singh SKCI, Terasaki M, Bonn VE, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821–5828.
   PubMed Web of Science ®Google Scholar
• Al-Hajj MWM, Benito-Hernandez A, Morrison SJ, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100::3983–8.
   PubMed Web of Science ®Google Scholar
• Collins ATBP, Hyde C, Stower MJ, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65:10946–10951.
   PubMed Web of Science ®Google Scholar
• Dalerba PCR, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med. 2007;58:267–284.
   PubMed Web of Science ®Google Scholar
• Wicha MSLS, Dontu G, Dontu G. Cancer stem cells: an old idea—a paradigm shift. Cancer Res. 2006;66(4):1883–1890.
   PubMed Web of Science ®Google Scholar
• Dalerba PDS, Park IK, Liu R, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA. 2007;104:10158–10163.
   PubMed Web of Science ®Google Scholar
• Choi K-JB IH, Ye S-K, Lee Y-H. Molecular targeted therapy for hepatocellular carcinoma: present status and future directions. Biol Pharm Bull. 2015;38:986–991.
   PubMed Web of Science ®Google Scholar
• Oishi N, Wang XW. Novel therapeutic strategies for targeting liver cancer stem cells. Int J Biol Sci. 2011;7:517–535.
   PubMed Web of Science ®Google Scholar
• Haraguchi N, Ishii H, Mimori K, et al. CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest. 2010;120:3326–3339.
   PubMed Web of Science ®Google Scholar
• Lee TKW, Castilho A, Cheung VCH, et al. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell. 2011;9:50–63.
   PubMed Web of Science ®Google Scholar
• Ma S, Chan K-W, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007;132:2542–2556.
   PubMed Web of Science ®Google Scholar
• Zhao W, Wang L, Han H, et al. 1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit. Cancer Cell. 2013;23:541–556.
   PubMed Web of Science ®Google Scholar
• Ishiguro KYI, Lewis-Tuffin L, Patel T. Targeting liver cancer stem cells using engineered biological nanoparticles for the treatment of hepatocellular cancer. Hepatol Commun. 2020;4:298–313.
   PubMed Web of Science ®Google Scholar
• Karg ESM, Ryan J, Forné I, et al. Ubiquitome analysis reveals PCNA-associated factor 15 (PAF15) as a specific ubiquitination target of UHRF1 in embryonic stem cells. J Mol Biol. 2007;429:3814–3824.
   Google Scholar
• De Biasio A, De Opakua AI, Mortuza GB, et al. Structure of p15(PAF)-PCNA complex and implications for clamp sliding during DNA replication and repair. Nat Commun. 2015;6:6439.
   PubMed Web of Science ®Google Scholar
• Kais Z, Barsky SH, Mathsyaraja H, et al. KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res. 2011;9:1091–1099.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Li K, Diao D, et al. Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro. Lab Invest. 2013;93:1276–1287.
   PubMed Web of Science ®Google Scholar
• Yuan R-H, Jeng Y-M, Pan H-W, et al. Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2007;13:5368–5376.
   PubMed Web of Science ®Google Scholar
• Kato T, Daigo Y, Aragaki M, et al. Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients. Lung Cancer. 2012;75:110–118.
   PubMed Web of Science ®Google Scholar
• Wang XJY, Jun S, Lee S, et al. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun. 2016;7:10633.
   PubMed Web of Science ®Google Scholar
• Zhuo Z, Hu J, Yang X, et al. Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo. Sci Rep. 2015;5:16185.
   PubMed Web of Science ®Google Scholar
• Duda P, Akula SM, Abrams SL, et al. Targeting GSK3 and associated signaling pathways involved in cancer. Cells. 2020;9:1110.
   Google Scholar
• Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012;21:283–296.
   PubMed Web of Science ®Google Scholar
• Shackleton MQE, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009;138:822–829.
   PubMed Web of Science ®Google Scholar
• Visvader JELG, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8:755–768.
   PubMed Web of Science ®Google Scholar
• Ji JYT, Budhu A, Forgues M, et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology. 2009;50:472–480.
   PubMed Web of Science ®Google Scholar
• Zhuang L, Wang X, Wang Z, et al. MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma. Cell Death Dis. 2017;8:e2804.
   PubMed Web of Science ®Google Scholar
• Xie Y, Du J, Liu Z, et al. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. J Exp Clin Cancer Res. 2019;38:7.
   PubMed Web of Science ®Google Scholar
• Kahraman DC, Kahraman T, Cetin-Atalay R. Targeting PI3K/Akt/mTOR pathway identifies differential expression and functional role of IL8 in liver cancer stem cell enrichment. Mol Cancer Ther. 2019;18:2146–2157.
   PubMed Web of Science ®Google Scholar
• Krishnankutty A, Kimura T, Saito T, et al. In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains. Sci Rep. 2017;7:8602.
   PubMed Web of Science ®Google Scholar
• Liu X, Yao Z. Chronic over-nutrition and dysregulation of GSK3 in diseases. Nutr Metab (Lond). 2016;13:49.
   PubMed Web of Science ®Google Scholar
• Liu G, Ouyang X, Sun Y, et al. The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling. Cell Death Differ. 2020;27:3258–3272.
   PubMed Web of Science ®Google Scholar
• Jin C, Liu Z, Li Y, et al. PCNA-associated factor P15(PAF), targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients. Int J Cancer. 2018;143:2973–2984.
   PubMed Web of Science ®Google Scholar